LRP1 and astrocytoma (excluding glioblastoma): It was demonstrated previously that the interaction of it with the lipoprotein receptor-related protein-1(LRP1) of low-density led to an inhibition of tumour cell proliferation, migration, and invasion in astrocytoma malignancy [46].